Life-threatening Idiopathic Nonhistaminergic Acquired Angioedema With Response to Lanadelumab

Gamboa, P; Galán, C; Arrien, A; Segurola, A; Jáuregui, I

Gamboa, P; Galán, C; Arrien, A; Segurola, A; Jáuregui, I.

Affiliation

Gamboa, P; Hospital Universitario Cruces. Allergy Department. Barakaldo. Spain
Galán, C; Hospital Universitario Cruces. Allergy Department. Barakaldo. Spain
Arrien, A; Hospital Universitario Cruces. Allergy Department. Barakaldo. Spain
Segurola, A; Hospital Universitario Cruces. Allergy Department. Barakaldo. Spain
Jáuregui, I; Hospital Universitario Cruces. Allergy Department. Barakaldo. Spain

J. investig. allergol. clin. immunol ; 34(1): 68-70, 2024.

Article in English | IBECS | ID: ibc-230823

Responsible library: ES1.1

Localization: ES15.1 - BNCS

Subject(s)

Humans; Female; Adult; Antibodies, Monoclonal, Humanized/therapeutic use; Angioedema/drug therapy; Treatment Outcome

Idiopathic bradykinergic angioedema; Landelumab; C1 inhibitor; Angioedema bradicininérgico idiopático; Lanadelumab; Inhibidor C1

Fulltext

Add to My VHL

XML

Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Antibodies, Monoclonal, Humanized / Angioedema Limits: Adult / Female / Humans Language: English Journal: J. investig. allergol. clin. immunol Year: 2024 Document type: Article Institution/Affiliation country: Hospital Universitario Cruces/Spain

Fulltext

Add to My VHL

XML

Search on Google